Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 667 entries
Sorted by: Best Match Show Resources per page
Encouraging minority scientists.

Nature immunology

[No authors listed]
PMID: 19692988
Nat Immunol. 2009 Sep;10(9):927. doi: 10.1038/ni0909-927.

The research community needs to increase the number of minority students who choose scientific research careers.

Cite
Encouraging minority scientists. Nat Immunol. 2009;10(9):927doi: 10.1038/ni0909-927.
(2009). Encouraging minority scientists. Nature immunology, 10(9), 927. https://doi.org/10.1038/ni0909-927
"Encouraging minority scientists." Nature immunology vol. 10,9 (2009): 927. doi: https://doi.org/10.1038/ni0909-927
Encouraging minority scientists. Nat Immunol. 2009 Sep;10(9):927. doi: 10.1038/ni0909-927. PMID: 19692988.
Copy Download .nbib Format: NLM
Support for peer review.

Nature immunology

[No authors listed]
PMID: 21079625
Nat Immunol. 2010 Dec;11(12):1063. doi: 10.1038/ni1210-1063.

No abstract available.

Cite
Support for peer review. Nat Immunol. 2010;11(12):1063doi: 10.1038/ni1210-1063.
(2010). Support for peer review. Nature immunology, 11(12), 1063. https://doi.org/10.1038/ni1210-1063
"Support for peer review." Nature immunology vol. 11,12 (2010): 1063. doi: https://doi.org/10.1038/ni1210-1063
Support for peer review. Nat Immunol. 2010 Dec;11(12):1063. doi: 10.1038/ni1210-1063. PMID: 21079625.
Copy Download .nbib Format: NLM
Pathways in opposition.

Nature immunology

Fehervari Z.
PMID: 28829445
Nat Immunol. 2017 Aug 22;18(9):961. doi: 10.1038/ni.3822.

No abstract available.

Cite
Fehervari Z. Pathways in opposition. Nat Immunol. 2017;18(9):961doi: 10.1038/ni.3822.
Fehervari, Z. (2017). Pathways in opposition. Nature immunology, 18(9), 961. https://doi.org/10.1038/ni.3822
Fehervari, Zoltan. "Pathways in opposition." Nature immunology vol. 18,9 (2017): 961. doi: https://doi.org/10.1038/ni.3822
Fehervari Z. Pathways in opposition. Nat Immunol. 2017 Aug 22;18(9):961. doi: 10.1038/ni.3822. PMID: 28829445.
Copy Download .nbib Format: NLM
Amplifying senescence.

Nature immunology

Visan I.
PMID: 28829447
Nat Immunol. 2017 Aug 22;18(9):961. doi: 10.1038/ni.3827.

No abstract available.

Cite
Visan I. Amplifying senescence. Nat Immunol. 2017;18(9):961doi: 10.1038/ni.3827.
Visan, I. (2017). Amplifying senescence. Nature immunology, 18(9), 961. https://doi.org/10.1038/ni.3827
Visan, Ioana. "Amplifying senescence." Nature immunology vol. 18,9 (2017): 961. doi: https://doi.org/10.1038/ni.3827
Visan I. Amplifying senescence. Nat Immunol. 2017 Aug 22;18(9):961. doi: 10.1038/ni.3827. PMID: 28829447.
Copy Download .nbib Format: NLM
Flowing mechanics.

Nature immunology

Fehervari Z.
PMID: 29777217
Nat Immunol. 2018 Jun;19(6):511. doi: 10.1038/s41590-018-0125-z.

No abstract available.

Cite
Fehervari Z. Flowing mechanics. Nat Immunol. 2018;19(6):511doi: 10.1038/s41590-018-0125-z.
Fehervari, Z. (2018). Flowing mechanics. Nature immunology, 19(6), 511. https://doi.org/10.1038/s41590-018-0125-z
Fehervari, Zoltan. "Flowing mechanics." Nature immunology vol. 19,6 (2018): 511. doi: https://doi.org/10.1038/s41590-018-0125-z
Fehervari Z. Flowing mechanics. Nat Immunol. 2018 Jun;19(6):511. doi: 10.1038/s41590-018-0125-z. PMID: 29777217.
Copy Download .nbib Format: NLM
TB prognostic marker.

Nature immunology

Visan I.
PMID: 30250181
Nat Immunol. 2018 Oct;19(10):1039. doi: 10.1038/s41590-018-0219-7.

No abstract available.

Cite
Visan I. TB prognostic marker. Nat Immunol. 2018;19(10):1039doi: 10.1038/s41590-018-0219-7.
Visan, I. (2018). TB prognostic marker. Nature immunology, 19(10), 1039. https://doi.org/10.1038/s41590-018-0219-7
Visan, Ioana. "TB prognostic marker." Nature immunology vol. 19,10 (2018): 1039. doi: https://doi.org/10.1038/s41590-018-0219-7
Visan I. TB prognostic marker. Nat Immunol. 2018 Oct;19(10):1039. doi: 10.1038/s41590-018-0219-7. PMID: 30250181.
Copy Download .nbib Format: NLM
Anti-tumor role of metformin.

Nature immunology

Dempsey LA.
PMID: 30250180
Nat Immunol. 2018 Oct;19(10):1039. doi: 10.1038/s41590-018-0224-x.

No abstract available.

Cite
Dempsey LA. Anti-tumor role of metformin. Nat Immunol. 2018;19(10):1039doi: 10.1038/s41590-018-0224-x.
Dempsey, L. A. (2018). Anti-tumor role of metformin. Nature immunology, 19(10), 1039. https://doi.org/10.1038/s41590-018-0224-x
Dempsey, Laurie A. "Anti-tumor role of metformin." Nature immunology vol. 19,10 (2018): 1039. doi: https://doi.org/10.1038/s41590-018-0224-x
Dempsey LA. Anti-tumor role of metformin. Nat Immunol. 2018 Oct;19(10):1039. doi: 10.1038/s41590-018-0224-x. PMID: 30250180.
Copy Download .nbib Format: NLM
Publisher Correction: The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells.

Nature immunology

Zuberbuehler MK, Parker ME, Wheaton JD, Espinosa JR, Salzler HR, Park E, Ciofani M.
PMID: 30816306
Nat Immunol. 2019 May;20(5):663. doi: 10.1038/s41590-019-0349-6.

In the version of this article initially published, the top right plot in Figure 4a was aligned incorrectly. The error has been corrected in the HTML and PDF versions of the article. The original and corrected figures are provided...

Cite
Zuberbuehler MK, Parker ME, Wheaton JD, et al. Publisher Correction: The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells. Nat Immunol. 2019;20(5):663doi: 10.1038/s41590-019-0349-6.
Zuberbuehler, M. K., Parker, M. E., Wheaton, J. D., Espinosa, J. R., Salzler, H. R., Park, E., & Ciofani, M. (2019). Publisher Correction: The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells. Nature immunology, 20(5), 663. https://doi.org/10.1038/s41590-019-0349-6
Zuberbuehler, Matthew K, et al. "Publisher Correction: The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells." Nature immunology vol. 20,5 (2019): 663. doi: https://doi.org/10.1038/s41590-019-0349-6
Zuberbuehler MK, Parker ME, Wheaton JD, Espinosa JR, Salzler HR, Park E, Ciofani M. Publisher Correction: The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells. Nat Immunol. 2019 May;20(5):663. doi: 10.1038/s41590-019-0349-6. PMID: 30816306.
Copy Download .nbib Format: NLM
Author Correction: At the end of the beginning: immunotherapies as living drugs.

Nature immunology

Feigal EG, DeWitt ND, Cantilena C, Peck C, Stroncek D.
PMID: 31388150
Nat Immunol. 2019 Oct;20(10):1405. doi: 10.1038/s41590-019-0476-0.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Feigal EG, DeWitt ND, Cantilena C, et al. Author Correction: At the end of the beginning: immunotherapies as living drugs. Nat Immunol. 2019;20(10):1405doi: 10.1038/s41590-019-0476-0.
Feigal, E. G., DeWitt, N. D., Cantilena, C., Peck, C., & Stroncek, D. (2019). Author Correction: At the end of the beginning: immunotherapies as living drugs. Nature immunology, 20(10), 1405. https://doi.org/10.1038/s41590-019-0476-0
Feigal, Ellen G, et al. "Author Correction: At the end of the beginning: immunotherapies as living drugs." Nature immunology vol. 20,10 (2019): 1405. doi: https://doi.org/10.1038/s41590-019-0476-0
Feigal EG, DeWitt ND, Cantilena C, Peck C, Stroncek D. Author Correction: At the end of the beginning: immunotherapies as living drugs. Nat Immunol. 2019 Oct;20(10):1405. doi: 10.1038/s41590-019-0476-0. PMID: 31388150.
Copy Download .nbib Format: NLM
Wound healing.

Nature immunology

Visan I.
PMID: 31431724
Nat Immunol. 2019 Sep;20(9):1089. doi: 10.1038/s41590-019-0484-0.

No abstract available.

Cite
Visan I. Wound healing. Nat Immunol. 2019;20(9):1089doi: 10.1038/s41590-019-0484-0.
Visan, I. (2019). Wound healing. Nature immunology, 20(9), 1089. https://doi.org/10.1038/s41590-019-0484-0
Visan, Ioana. "Wound healing." Nature immunology vol. 20,9 (2019): 1089. doi: https://doi.org/10.1038/s41590-019-0484-0
Visan I. Wound healing. Nat Immunol. 2019 Sep;20(9):1089. doi: 10.1038/s41590-019-0484-0. PMID: 31431724.
Copy Download .nbib Format: NLM
Corrigendum: IL-6 as a keystone cytokine in health and disease.

Nature immunology

Hunter CA, Jones SA.
PMID: 29044237
Nat Immunol. 2017 Oct 18;18(11):1271. doi: 10.1038/ni1117-1271b.

This corrects the article DOI: 10.1038/ni.3153.

Cite
Hunter CA, Jones SA. Corrigendum: IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2017;18(11):1271doi: 10.1038/ni1117-1271b.
Hunter, C. A., & Jones, S. A. (2017). Corrigendum: IL-6 as a keystone cytokine in health and disease. Nature immunology, 18(11), 1271. https://doi.org/10.1038/ni1117-1271b
Hunter, Christopher A, and Jones, Simon A. "Corrigendum: IL-6 as a keystone cytokine in health and disease." Nature immunology vol. 18,11 (2017): 1271. doi: https://doi.org/10.1038/ni1117-1271b
Hunter CA, Jones SA. Corrigendum: IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2017 Oct 18;18(11):1271. doi: 10.1038/ni1117-1271b. PMID: 29044237.
Copy Download .nbib Format: NLM
What is the point of the gallbladder?.

Nature immunology

Fehervari Z.
PMID: 29044241
Nat Immunol. 2017 Oct 18;18(11):1189. doi: 10.1038/ni.3865.

No abstract available.

Cite
Fehervari Z. What is the point of the gallbladder?. Nat Immunol. 2017;18(11):1189doi: 10.1038/ni.3865.
Fehervari, Z. (2017). What is the point of the gallbladder?. Nature immunology, 18(11), 1189. https://doi.org/10.1038/ni.3865
Fehervari, Zoltan. "What is the point of the gallbladder?." Nature immunology vol. 18,11 (2017): 1189. doi: https://doi.org/10.1038/ni.3865
Fehervari Z. What is the point of the gallbladder?. Nat Immunol. 2017 Oct 18;18(11):1189. doi: 10.1038/ni.3865. PMID: 29044241.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 667 entries